What term corresponds to the regulatory act that provides incentives for developing drugs for rare diseases?

What term corresponds to the regulatory act that provides incentives for developing drugs for rare diseases?

• A. Orphan Drugs
• B. Expedited Approval
• C. Orphan Drug Act
• D. Treatment INDs

Answer: (C)

This item tests your knowledge of a law that provides incentives for developing drugs for rare diseases. The Orphan Drug Act is the U.S. statute designed to spur such development by offering incentives like seven years of market exclusivity for approved orphan drugs, tax credits for qualifying clinical research, grant funding, and waivers of certain FDA application fees. These incentives make it financially feasible to invest in therapies for conditions that affect only small patient populations, where market returns would otherwise be unlikely. Other options refer to the drugs themselves, a fast-track approval pathway, or early-access mechanisms, not the statute. So the correct term is the Orphan Drug Act.

This item tests your knowledge of a law that provides incentives for developing drugs for rare diseases. The Orphan Drug Act is the U.S. statute designed to spur such development by offering incentives like seven years of market exclusivity for approved orphan drugs, tax credits for qualifying clinical research, grant funding, and waivers of certain FDA application fees. These incentives make it financially feasible to invest in therapies for conditions that affect only small patient populations, where market returns would otherwise be unlikely. Other options refer to the drugs themselves, a fast-track approval pathway, or early-access mechanisms, not the statute. So the correct term is the Orphan Drug Act.